Johannes Czernin
Affiliations: | Molec & Med Pharmacology 0639 | University of California, Los Angeles, Los Angeles, CA |
Area:
Immunology, Human Development, BiochemistryWebsite:
https://www.uclahealth.org/johannes-czerninGoogle:
"Johannes Czernin"Mean distance: (not calculated yet)
Children
Sign in to add trainee| Jason Thanh Lee | grad student | 2007- | David Geffen School of Medicine at UCLA (Imaging Tree) |
| Amanda L. Kesner | grad student | 2003 | UCLA |
| Isabel J. Hildebrandt | grad student | 2007 | UCLA |
| Arash Safaei | grad student | 2007 | UCLA |
| Wayne R. Austin | grad student | 2012 | UCLA |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chen BY, Salas JR, Trias AO, et al. (2022) Targeting deoxycytidine kinase improves symptoms in mouse models of multiple sclerosis. Immunology |
| Beyer T, Czernin J, Freudenberg LS, et al. (2022) A 2022 INTERNATIONAL SURVEY ON THE STATUS OF PROSTATE CANCER THERANOSTICS. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine |
| Czernin J, Adams T, Calais J. (2022) More Unacceptable Denials: Now It's PSMA-Targeted PET/CT Imaging. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 63: 969-970 |
| Le TM, Lee HR, Abt ER, et al. (2022) F-FDG PET visualizes systemic STING agonist-induced lymphocyte activation in preclinical models. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine |
| Abt ER, Le TM, Dann AM, et al. (2022) Reprogramming of nucleotide metabolism by interferon confers dependence on the replication stress response pathway in pancreatic cancer cells. Cell Reports. 38: 110236 |
| Sonni I, Felker ER, Lenis AT, et al. (2021) Head-to-head comparison of Ga-PSMA-11 PET/CT and mpMRI with histopathology gold-standard in the detection, intra-prostatic localization and local extension of primary prostate cancer: results from a prospective single-center imaging trial. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine |
| Crompton J, Armstrong WR, Eckardt MA, et al. (2021) F-FLT PET/CT as a prognostic imaging biomarker of disease specific survival in patients with primary soft tissue sarcoma. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine |
| Liang K, Abt ER, Le TM, et al. (2021) STING-driven interferon signaling triggers metabolic alterations in pancreas cancer cells visualized by [F]FLT PET imaging. Proceedings of the National Academy of Sciences of the United States of America. 118 |
| Czernin J, Radu C, Ribas A. (2021) Leadership Focus on Advancing Cancer Research and Treatment: A Conversation Between Johannes Czernin, Caius Radu, and Antoni Ribas. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 62: 1178-1180 |
| Benz MR, Armstrong WR, Ceci F, et al. (2021) F-FDG PET/CT imaging biomarkers for early and late evaluation of response to first-line chemotherapy in patients with pancreatic ductal adenocarcinoma. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine |